Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2009 2
2010 2
2011 1
2012 3
2013 3
2014 1
2015 1
2016 6
2017 8
2018 4
2019 4
2020 3
2021 1
2022 2
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
The Comparative Effectiveness of Vasoactive Treatments for Hepatorenal Syndrome: A Systematic Review and Network Meta-Analysis.
Pitre T, Kiflen M, Helmeczi W, Dionne JC, Rewa O, Bagshaw SM, Needham-Nethercott N, Alhazzani W, Zeraatkar D, Rochwerg B. Pitre T, et al. Crit Care Med. 2022 Oct 1;50(10):1419-1429. doi: 10.1097/CCM.0000000000005595. Epub 2022 Sep 12. Crit Care Med. 2022. PMID: 35777925
OBJECTIVE: Hepatorenal syndrome (HRS) is associated with high rates of morbidity and mortality. ...
OBJECTIVE: Hepatorenal syndrome (HRS) is associated with high rates of morbidity and mortality. ...
Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis.
Wang H, Liu A, Bo W, Feng X, Hu Y. Wang H, et al. Medicine (Baltimore). 2018 Apr;97(16):e0431. doi: 10.1097/MD.0000000000010431. Medicine (Baltimore). 2018. PMID: 29668606 Free PMC article. Review.
BACKGROUND: Hepatorenal syndrome is a fatal complication of advanced cirrhosis. ...Hepatorenal syndrome reverse rate was 42.0% in the terlipressin group and 26.2% in the non-terlipressin group. ...
BACKGROUND: Hepatorenal syndrome is a fatal complication of advanced cirrhosis. ...Hepatorenal syndrome reverse …
Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials.
Bai Z, Wang L, Wang R, Zou M, Méndez-Sánchez N, Romeiro FG, Cheng G, Qi X. Bai Z, et al. Hepatol Int. 2022 Dec;16(6):1468-1483. doi: 10.1007/s12072-022-10374-z. Epub 2022 Sep 1. Hepatol Int. 2022. PMID: 36048318
BACKGROUND: Human albumin infusion is effective for controlling systemic inflammation, thereby probably managing some liver cirrhosis-related complications, such as spontaneous bacterial peritonitis (SBP), hepatic encephalopathy (HE), and hepatorenal syndrome. Howev …
BACKGROUND: Human albumin infusion is effective for controlling systemic inflammation, thereby probably managing some liver cirrhosis-relate …
Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis.
Song T, Rössle M, He F, Liu F, Guo X, Qi X. Song T, et al. Dig Liver Dis. 2018 Apr;50(4):323-330. doi: 10.1016/j.dld.2018.01.123. Epub 2018 Feb 17. Dig Liver Dis. 2018. PMID: 29422242 Review.
BACKGROUND: Hepatorenal syndrome is a severe complication of advanced liver diseases with a dismal prognosis. ...The pooled short-term and 1-year survival rates were 72% and 47% in type 1 hepatorenal syndrome and 86% and 64% in type 2 hepatorenal …
BACKGROUND: Hepatorenal syndrome is a severe complication of advanced liver diseases with a dismal prognosis. ...The pooled sh …
Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis.
Dobre M, Demirjian S, Sehgal AR, Navaneethan SD. Dobre M, et al. Int Urol Nephrol. 2011 Mar;43(1):175-84. doi: 10.1007/s11255-010-9725-8. Epub 2010 Mar 20. Int Urol Nephrol. 2011. PMID: 20306131 Free PMC article. Review.
BACKGROUND: Hepatorenal syndrome (HRS) is a common complication in patients with cirrhosis or fulminant liver failure. ...
BACKGROUND: Hepatorenal syndrome (HRS) is a common complication in patients with cirrhosis or fulminant liver failure. ...
Terlipressin for hepatorenal syndrome.
Gluud LL, Christensen K, Christensen E, Krag A. Gluud LL, et al. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD005162. doi: 10.1002/14651858.CD005162.pub3. Cochrane Database Syst Rev. 2012. PMID: 22972083 Updated. Review.
BACKGROUND: Clinical trials suggest that terlipressin improves renal function in hepatorenal syndrome, but the evidence concerning mortality is equivocal. ...SELECTION CRITERIA: Randomised clinical trials involving patients with type 1 or type 2 hepatorenal …
BACKGROUND: Clinical trials suggest that terlipressin improves renal function in hepatorenal syndrome, but the evidence concer …
Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trials.
Tandon P, Bain VG, Tsuyuki RT, Klarenbach S. Tandon P, et al. Aliment Pharmacol Ther. 2007 May 1;25(9):1017-28. doi: 10.1111/j.1365-2036.2007.03303.x. Aliment Pharmacol Ther. 2007. PMID: 17439502 Free article. Review.
BACKGROUND: Although reversal of pretransplant renal dysfunction in hepatorenal syndrome reduces post-transplant complications, the overall impact on morbidity and mortality requires clarification. AIM: To review trials of pharmacologic interventions in hepatoren …
BACKGROUND: Although reversal of pretransplant renal dysfunction in hepatorenal syndrome reduces post-transplant complications …
Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1.
Gifford FJ, Morling JR, Fallowfield JA. Gifford FJ, et al. Aliment Pharmacol Ther. 2017 Mar;45(5):593-603. doi: 10.1111/apt.13912. Epub 2017 Jan 4. Aliment Pharmacol Ther. 2017. PMID: 28052382 Free article. Review.
BACKGROUND: Hepatorenal syndrome type 1 (HRS1) is a functional, rapidly progressive, potentially reversible form of acute kidney injury occurring in patients with cirrhosis. ...There is continued need for safe and effective treatment options for hepatorenal …
BACKGROUND: Hepatorenal syndrome type 1 (HRS1) is a functional, rapidly progressive, potentially reversible form of acute kidn …
Pentoxifylline for alcoholic hepatitis.
Whitfield K, Rambaldi A, Wetterslev J, Gluud C. Whitfield K, et al. Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD007339. doi: 10.1002/14651858.CD007339.pub2. Cochrane Database Syst Rev. 2009. PMID: 19821406 Free PMC article. Review.
Meta-analysis showed that pentoxifylline reduced the hepatic-related mortality due to hepatorenal syndrome (RR 0.40; 95% CI 0.22 to 0.71), but trial sequential analysis did not support this result. ...AUTHORS' CONCLUSIONS: The current available data may indicate a p …
Meta-analysis showed that pentoxifylline reduced the hepatic-related mortality due to hepatorenal syndrome (RR 0.40; 95% CI 0. …
Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.
Allegretti AS, Israelsen M, Krag A, Jovani M, Goldin AH, Schulman AR, Winter RW, Gluud LL. Allegretti AS, et al. Cochrane Database Syst Rev. 2017 Jun 14;6(6):CD005162. doi: 10.1002/14651858.CD005162.pub4. Cochrane Database Syst Rev. 2017. PMID: 29943803 Free PMC article. Review.
BACKGROUND: Hepatorenal syndrome is a potentially reversible renal failure associated with severe liver disease. ...The previous version of this systematic review found a potential beneficial effect of terlipressin on mortality and renal function in people with cirr …
BACKGROUND: Hepatorenal syndrome is a potentially reversible renal failure associated with severe liver disease. ...The previo …
46 results